Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 88

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Liposomal drug delivery strategies to eradicate bacterial biofilms: Challenges, recent advances, and future perspectives

Panthi, Vijay Kumar, Fairfull-Smith, Kathryn E., Islam, Nazrul · 2024 · International Journal of Pharmaceutics

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijpharm.2024.124046

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 149

  1. Abbasian, 2014, Adsorption of DNA on colloidal Ag nanoparticles: effects of nanoparticle surface charge, base content and length of DNA, Colloids Surf. B Biointerfaces, 116, 439, 10.1016/j.colsurfb.2014.01.023 · doi:10.1016/j.colsurfb.2014.01.023
  2. Abebe, 2020, The role of bacterial biofilm in antibiotic resistance and food contamination, Int. J. Microbiol., 2020, 1705814, 10.1155/2020/1705814 · DOI · Paper page
  3. Afrasiabi, 2023, In vitro study of nanoliposomes containing curcumin and doxycycline for enhanced antimicrobial photodynamic therapy against Aggregatibacter actinomycetemcomitans, Sci. Rep., 13, 11552, 10.1038/s41598-023-38812-4 · DOI
  4. Akbarzadeh, 2013, Liposome: classification, preparation, and applications, Nanoscale Res. Lett., 8, 102, 10.1186/1556-276X-8-102 · DOI · Paper page
  5. Alhajlan, 2013, Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors, Antimicrob. Agents Chemother., 57, 2694, 10.1128/AAC.00235-13 · DOI
  6. Alhariri, 2013, Liposomal antibiotics for the treatment of infectious diseases, Exp. Opin. Drug Deliv., 10, 1515, 10.1517/17425247.2013.822860 · DOI
  7. Aljihani, 2020, Enhancing azithromycin antibacterial activity by encapsulation in liposomes/liposomal-N-acetylcysteine formulations against resistant clinical strains of Escherichia coli, Saudi J. Biol. Sci., 27, 3065, 10.1016/j.sjbs.2020.09.012 · doi:10.1016/j.sjbs.2020.09.012
  8. Allesen-Holm, 2006, A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms, Mol. Microbiol., 59, 1114, 10.1111/j.1365-2958.2005.05008.x · DOI · Paper page
  9. Al-Wrafy, 2022, Nanoparticles approach to eradicate bacterial biofilm-related infections: a critical review, Chemosphere, 288
  10. Alzahrani, 2022, Liposome-encapsulated tobramycin and IDR-1018 peptide mediated biofilm disruption and enhanced antimicrobial activity against pseudomonas aeruginosa, Pharmaceutics, 14, 10.3390/pharmaceutics14050960 · DOI
  11. Asma, 2022, An overview of biofilm formation-combating strategies and mechanisms of action of antibiofilm agents, Life (Basel), 12
  12. Baek, 2018, A programmable lipid-polymer hybrid nanoparticle system for localized, sustained antibiotic delivery to Gram-positive and Gram-negative bacterial biofilms, Nanoscale Horiz., 3, 305, 10.1039/C7NH00167C · DOI
  13. Bandara, 2020, A novel, quorum sensor-infused liposomal drug delivery system suppresses Candida albicans biofilms, Int. J. Pharm., 578, 10.1016/j.ijpharm.2020.119096 · DOI
  14. Basnet, 2013, Nanodelivery systems for improved topical antimicrobial therapy, Curr. Pharm. Des., 19, 7237, 10.2174/138161281941131219124856 · doi:10.2174/138161281941131219124856
  15. Bazrgari, 2020, Effect of the nanoliposomal formulations of rifampin and N-acetyl cysteine on staphylococcus epidermidis biofilm, Nanomed. J., 7, 131
  16. Bhatia, 2021, Combinatorial liposomes of berberine and curcumin inhibit biofilm formation and intracellular methicillin resistant Staphylococcus aureus infections and associated inflammation, J. Mater. Chem. B, 9, 864, 10.1039/D0TB02036B · DOI
  17. Bi, 2021, Therapeutic strategies against bacterial biofilms, Fund. Res., 1, 193
  18. Chen, 2023, Photodynamic cationic ultrasmall copper oxide nanoparticles-loaded liposomes for alleviation of MRSA biofilms, Int. J. Nanomed., 18, 5441, 10.2147/IJN.S426682 · doi:10.2147/ijn.s426682
  19. Coughlin, 1985, A pH titration study on the ionic bridging within lipopolysaccharide aggregates, Biochim. Biophys. Acta, 821, 404, 10.1016/0005-2736(85)90044-6 · doi:10.1016/0005-2736(85)90044-6
  20. Cressey, 2022, Novel liposome-like assemblies composed of phospholipid-porphyrin conjugates with photothermal and photodynamic activities against bacterial biofilms, Int. J. Pharm., 623, 10.1016/j.ijpharm.2022.121915 · doi:10.1016/j.ijpharm.2022.121915
  21. Cui, 2016, Liposome containing cinnamon oil with antibacterial activity against methicillin-resistant Staphylococcus aureus biofilm, Biofouling, 32, 215, 10.1080/08927014.2015.1134516 · DOI · Paper page
  22. Ding, 2022, Stimuli-responsive nanocarriers for bacterial biofilm treatment, Rare Met., 41, 482, 10.1007/s12598-021-01802-4 · DOI
  23. Dong, 2015, Distribution and Inhibition of Liposomes on Staphylococcus aureus and Pseudomonas aeruginosa Biofilm, PLoS One, 10, e0131806, 10.1371/journal.pone.0131806 · DOI
  24. Dragoš, 2017, The peculiar functions of the bacterial extracellular matrix, Trends Microbiol., 25, 257, 10.1016/j.tim.2016.12.010 · DOI · Paper page
  25. Drulis-Kawa, 2010, Liposomes as delivery systems for antibiotics, Int. J. Pharm., 387, 187, 10.1016/j.ijpharm.2009.11.033 · DOI · Paper page
  26. Ekonomou, 2022, Development of geraniol-loaded liposomal nanoformulations against salmonella colonization in the pig gut, J. Agric. Food Chem., 70, 7004, 10.1021/acs.jafc.2c00910 · DOI
  27. Ellboudy, 2023, Cinnamon oil-loaded nanoliposomes with potent antibacterial and antibiofilm activities, Molecules, 28, 10.3390/molecules28114492 · DOI
  28. Esparza-Soto, 2003, Biosorption of humic and fulvic acids to live activated sludge biomass, Water Res., 37, 2301, 10.1016/S0043-1354(02)00630-9 · DOI
  29. Fang, 2021, Facile biofilm penetration of cationic liposomes loaded with DNase I/proteinase K to eradicate cutibacterium acnes for treating cutaneous and catheter infections, Int. J. Nanomed., 16, 8121, 10.2147/IJN.S335804 · DOI
  30. Ferreira, 2021, Liposomes as antibiotic delivery systems: a promising nanotechnological strategy against antimicrobial resistance, Molecules, 26, 10.3390/molecules26072047 · DOI · Paper page
  31. Festa, 2021, A Study on the antimicrobial and antibiofilm peptide 1018–K6 as potential alternative to antibiotics against food-pathogen salmonella enterica, Foods, 10, 10.3390/foods10061372 · DOI
  32. Flemming, 2010, The biofilm matrix, Nat. Rev. Microbiol., 8, 623, 10.1038/nrmicro2415 · DOI · Paper page
  33. Forier, 2014, Probing the size limit for nanomedicine penetration into Burkholderia multivorans and Pseudomonas aeruginosa biofilms, J. Control Release, 195, 21, 10.1016/j.jconrel.2014.07.061 · DOI
  34. Forier, 2014, Lipid and polymer nanoparticles for drug delivery to bacterial biofilms, J. Control Release, 190, 607, 10.1016/j.jconrel.2014.03.055 · DOI · Paper page
  35. Fu, 2019, Synergistic antibacterial effect of ultrasound microbubbles combined with chitosan-modified polymyxin B-loaded liposomes on biofilm-producing Acinetobacter baumannii, Int. J. Nanomed., 14, 1805, 10.2147/IJN.S186571 · DOI
  36. Fu, 2021, Strategies for interfering with bacterial early stage biofilms, Front Microbiol., 12, 10.3389/fmicb.2021.675843 · DOI
  37. Fulaz, 2019, Nanoparticle-biofilm interactions: the role of the EPS matrix, Trends Microbiol., 27, 915, 10.1016/j.tim.2019.07.004 · DOI · Paper page
  38. Ganta, 2008, A review of stimuli-responsive nanocarriers for drug and gene delivery, J. Control Release, 126, 187, 10.1016/j.jconrel.2007.12.017 · DOI · Paper page
  39. Gerayelou, 2021, Dual antibiotic and diffusible signal factor combination nanoliposomes for combating staphylococcus epidermidis biofilm, Adv. Pharm. Bull., 11, 684, 10.34172/apb.2021.077 · doi:10.34172/apb.2021.077
  40. Gholizadeh, 2018, Anti-GD2 immunoliposomes for targeted delivery of the survivin inhibitor sepantronium bromide (YM155) to neuroblastoma tumor cells, Pharm. Res., 35, 85, 10.1007/s11095-018-2373-x · DOI
  41. Giordani, 2019, Liposomes containing biosurfactants isolated from Lactobacillus gasseri exert antibiofilm activity against methicillin resistant Staphylococcus aureus strains, Eur. J. Pharm. Biopharm., 139, 246, 10.1016/j.ejpb.2019.04.011 · DOI · Paper page
  42. Habimana, 2011, Diffusion of nanoparticles in biofilms is altered by bacterial cell wall hydrophobicity, Appl. Environ. Microbiol., 77, 367, 10.1128/AEM.02163-10 · DOI
  43. Habimana, 2014, The role of cell-surface interactions in bacterial initial adhesion and consequent biofilm formation on nanofiltration/reverse osmosis membranes, J. Membr. Sci., 454, 82, 10.1016/j.memsci.2013.11.043 · DOI · Paper page
  44. Hajipour, 2012, Antibacterial properties of nanoparticles, Trends Biotechnol., 30, 499, 10.1016/j.tibtech.2012.06.004 · DOI · Paper page
  45. Harper, 2019, Diminishing biofilm resistance to antimicrobial nanomaterials through electrolyte screening of electrostatic interactions, Colloids Surf. B Biointerf., 173, 392, 10.1016/j.colsurfb.2018.09.018 · DOI
  46. Hawas, 2022, Combination therapies for biofilm inhibition and eradication: a comparative review of laboratory and preclinical studies, Front Cell Infect. Microbiol., 12, 10.3389/fcimb.2022.850030 · DOI
  47. Heinonen, 2021, The antimicrobial peptide TAT-RasGAP317-326 inhibits the formation and expansion of bacterial biofilms in vitro, J. Glob. Antimicrob. Resis., 25, 227, 10.1016/j.jgar.2021.03.022 · DOI
  48. Hemmingsen, 2023, Tailored anti-biofilm activity - liposomal delivery for mimic of small antimicrobial peptide, Biomater. Adv., 145, 10.1016/j.bioadv.2022.213238 · DOI
  49. Hou, 2017, Lysozyme associated liposomal gentamicin inhibits bacterial biofilm, Int. J. Mol. Sci., 18, 10.3390/ijms18040784 · DOI
  50. Hou, 2017, Lysozyme associated liposomal gentamicin inhibits bacterial biofilm, Int. J. Mol. Sci., 18, 784, 10.3390/ijms18040784 · DOI
  51. Hu, 2023, Functional liposome loaded curcumin for the treatment of Streptococcus mutans biofilm, Front. Chem., 11, 10.3389/fchem.2023.1160521 · DOI
  52. Huangfu, 2019, A review on the interactions between engineered nanoparticles with extracellular and intracellular polymeric substances from wastewater treatment aggregates, Chemosphere, 219, 766, 10.1016/j.chemosphere.2018.12.044 · DOI
  53. Hurler, 2013, Liposomes-in-hydrogel delivery system with mupirocin: in vitro antibiofilm studies and in vivo evaluation in mice burn model, Biomed. Res. Int., 2013, 10.1155/2013/498485 · doi:10.1155/2013/498485
  54. Ibaraki, 2020, The effects of surface properties of liposomes on their activity against Pseudomonas aeruginosa PAO-1 biofilm, J. Drug Deliv. Sci. Technol., 57
  55. Ikuma, 2014, Deposition of nanoparticles onto polysaccharide-coated surfaces: implications for nanoparticle–biofilm interactions, Environ. Sci. Nano, 1, 117, 10.1039/C3EN00075C · doi:10.1039/c3en00075c
  56. Ikuma, 2015, When nanoparticles meet biofilms-interactions guiding the environmental fate and accumulation of nanoparticles, Front Microbiol., 6, 591, 10.3389/fmicb.2015.00591 · DOI · Paper page
  57. Jardeleza, 2014, Liposome-encapsulated ISMN: a novel nitric oxide-based therapeutic agent against Staphylococcus aureus biofilms, PLoS One, 9, e92117, 10.1371/journal.pone.0092117 · DOI
  58. Jha, 2023, A comprehensive review on pharmacokinetic studies of vaccines: impact of delivery route, carrier-and its modulation on immune response, Environ. Res., 236
  59. Jia, 2010, Characterization of the interaction between liposomal formulations and Pseudomonas aeruginosa, J. Liposome Res, 20, 134, 10.3109/08982100903218892 · DOI
  60. Joo, 2018, Factors impacting the interactions of engineered nanoparticles with bacterial cells and biofilms: Mechanistic insights and state of knowledge, J. Environ. Manage., 225, 62, 10.1016/j.jenvman.2018.07.084 · DOI
  61. Joshi, 2020, Interactions of gold and silver nanoparticles with bacterial biofilms: molecular interactions behind inhibition and resistance, Int. J. Mol. Sci., 21, 7658, 10.3390/ijms21207658 · DOI · Paper page
  62. Kannan, 2021, Liposome encapsulated surfactant abetted copper nanoparticles alleviates biofilm mediated virulence in pathogenic Pseudomonas aeruginosa and MRSA, Sci. Rep., 11, 1102, 10.1038/s41598-020-79976-7 · DOI
  63. Kassinger, 2020, Biofilm architecture: an emerging synthetic biology target, Synth. Syst. Biotechnol., 5, 1, 10.1016/j.synbio.2020.01.001 · DOI
  64. Khan, 2020, Chitosan and their derivatives: antibiofilm drugs against pathogenic bacteria, Colloids Surf. B Biointerf., 185, 10.1016/j.colsurfb.2019.110627 · DOI · Paper page
  65. Kluzek, 2022, Designer liposomic nanocarriers are effective biofilm eradicators, ACS Nano, 16, 15792, 10.1021/acsnano.2c04232 · DOI
  66. Koo, 2017, Targeting microbial biofilms: current and prospective therapeutic strategies, Nat. Rev. Microbiol., 15, 740, 10.1038/nrmicro.2017.99 · DOI · Paper page
  67. Krsmanovic, 2021, Hydrodynamics and surface properties influence biofilm proliferation, Adv. Colloid Interface Sci., 288, 10.1016/j.cis.2020.102336 · DOI · Paper page
  68. Kumar, 2023, Advances in nanotechnology for biofilm inhibition, ACS Omega, 8, 21391, 10.1021/acsomega.3c02239 · DOI · Paper page
  69. Leewenhoeck, 1935, Containing some microscopical observations, about animals in the scurf of the teeth, the substance call'd worms in the nose, the cuticula consisting of scales, Phil. Trans., 14, 568, 10.1098/rstl.1684.0030 · DOI
  70. Lewenza, 2013, Extracellular DNA-induced antimicrobial peptide resistance mechanisms in Pseudomonas aeruginosa, Front Microbiol., 4, 21, 10.3389/fmicb.2013.00021 · DOI
  71. Li, 2016, The spherical nanoparticle-encapsulated chlorhexidine enhances anti-biofilm efficiency through an effective releasing mode and close microbial interactions, Int. J. Nanomed., 11, 2471
  72. Li, 2023, In situ gelling hydrogel loaded with berberine liposome for the treatment of biofilm-infected wounds, Front Bioeng. Biotechnol., 11, 1189010, 10.3389/fbioe.2023.1189010 · DOI
  73. Liang, 2007, Interaction forces between colloidal particles in liquid: theory and experiment, Adv. Colloid Interf. Sci., 134–135, 151, 10.1016/j.cis.2007.04.003 · DOI · Paper page
  74. Lin, 2021, The antibiofilm nanosystems for improved infection inhibition of microbes in skin, Molecules, 26, 10.3390/molecules26216392 · DOI
  75. Liu, 2016, Surface-adaptive, antimicrobially loaded, micellar nanocarriers with enhanced penetration and killing efficiency in staphylococcal biofilms, ACS Nano, 10, 4779, 10.1021/acsnano.6b01370 · DOI · Paper page
  76. Liu, 2018, Nanocarriers with conjugated antimicrobials to eradicate pathogenic biofilms evaluated in murine in vivo and human ex vivo infection models, Acta Biomater., 79, 331, 10.1016/j.actbio.2018.08.038 · DOI
  77. Luo, 2022, Advances in application of ultraviolet irradiation for biofilm control in water and wastewater infrastructure, J. Hazard. Mater., 421, 10.1016/j.jhazmat.2021.126682 · DOI
  78. Ma, 2016, Biofilm mitigation by drug (gentamicin)-loaded liposomes promoted by pulsed ultrasound, J. Acoust. Soc. Am., 140, EL534, 10.1121/1.4972336 · doi:10.1121/1.4972336
  79. Makhlouf, 2023, Liposomes-based drug delivery systems of anti-biofilm agents to combat bacterial biofilm formation, Antibiotics (Basel), 12
  80. Mantovani, 2011, Neutrophils in the activation and regulation of innate and adaptive immunity, Nat. Rev. Immunol., 11, 519, 10.1038/nri3024 · DOI · Paper page
  81. Meng, 2016, Multi-functional liposomes enhancing target and antibacterial immunity for antimicrobial and anti-biofilm against methicillin-resistant staphylococcus aureus, Pharm. Res., 33, 763, 10.1007/s11095-015-1825-9 · DOI
  82. Messiaen, 2013, Transport of nanoparticles and tobramycin-loaded liposomes in Burkholderia cepacia complex biofilms, PLoS One, 8, e79220, 10.1371/journal.pone.0079220 · DOI
  83. Milani, 2023, Increased antibiofilm and growth inhibitory effect of Imipenem/Cilastatin nanoliposomes against clinical Pseudomonas aeruginosa isolates, J. Mater. Sci. Mater. Med., 34, 47, 10.1007/s10856-023-06752-0 · doi:10.1007/s10856-023-06752-0
  84. Mishra, 2023, Therapeutic strategies against biofilm infections, Life (Basel), 13, 1
  85. Mishra, 2023, Therapeutic strategies against biofilm infections, Life, 13, 172, 10.3390/life13010172 · DOI
  86. Mishra, 2004, PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles, Eur. J. Cell Biol., 83, 97, 10.1078/0171-9335-00363 · DOI · Paper page
  87. Mu, 2016, Potent antibacterial nanoparticles against biofilm and intracellular bacteria, Sci. Rep., 6, 18877, 10.1038/srep18877 · DOI · Paper page
  88. Mugabe, 2006, Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa, Antimicrob. Agents Chemother., 50, 2016, 10.1128/AAC.01547-05 · DOI · Paper page
  89. Mukherjee, 2023, Nanotechnology based therapeutic approaches: an advanced strategy to target the biofilm of ESKAPE pathogens, Mater. Adv., 4, 2544, 10.1039/D2MA00846G · DOI
  90. Munaweera, 2018, Temperature-sensitive liposomal ciprofloxacin for the treatment of biofilm on infected metal implants using alternating magnetic fields, Int. J. Hyperthermia, 34, 189, 10.1080/02656736.2017.1422028 · DOI
  91. Natsaridis, 2022, Moxifloxacin liposomes: effect of liposome preparation method on physicochemical properties and antimicrobial activity against staphylococcus epidermidis, Pharmaceutics, 14, 10.3390/pharmaceutics14020370 · DOI
  92. Ommen, 2022, Aptamer-targeted drug delivery for staphylococcus aureus biofilm, Front Cell Infect. Microbiol., 12, 10.3389/fcimb.2022.814340 · doi:10.3389/fcimb.2022.814340
  93. Pangeni, 2018, Preparation, characterization, and in vivo evaluation of an oral multiple nanoemulsive system for co-delivery of pemetrexed and quercetin, Pharmaceutics, 10, 10.3390/pharmaceutics10030158 · DOI
  94. Pangeni, 2018, Enhanced oral absorption of pemetrexed by ion-pairing complex formation with deoxycholic acid derivative and multiple nanoemulsion formulations: preparation, characterization, and in vivo oral bioavailability and anticancer effect, Int. J. Nanomed., 13, 3329, 10.2147/IJN.S167958 · DOI
  95. Panlilio, 2021, The role of extracellular DNA in the formation, architecture, stability, and treatment of bacterial biofilms, Biotechnol. Bioeng., 118, 2129, 10.1002/bit.27760 · DOI · Paper page
  96. Panthi, 2022, Formulation and development of adapalene topical nanohydrogel using different surfactants and cosurfactants for antiacne activity. In vitro and ex vivo evaluation, J. Nanomater., 2022, 19, 10.1155/2022/6889293 · DOI
  97. Panthi, 2023, Nanoformulations-based metronomic chemotherapy: mechanism, challenges, recent advances, and future perspectives, Pharmaceutics, 15, 10.3390/pharmaceutics15041192 · DOI
  98. Panthi, 2023, The significance of quercetin-loaded advanced nanoformulations for the management of diabetic wounds, Nanomedicine (Lond.), 18, 391, 10.2217/nnm-2022-0281 · DOI
  99. Panthi, 2024, Antibiotic loaded inhalable liposomal nanoparticles against lower respiratory tract infections: challenges, recent advances, and future perspectives, J. Drug Deliv. Sci. Technol., 94
  100. Panthi, 2022, Formulation and development of a water-in-oil emulsion-based luliconazole cream. In vitro characterization and analytical method validation by RP-HPLC, Int. J. Anal. Chem., 2022, 7273840, 10.1155/2022/7273840 · doi:10.1155/2022/7273840
  101. Patil, 2019, Mapping fusogenicity of ciprofloxacin-loaded liposomes with bacterial cells, AAPS PharmSciTech, 20, 180, 10.1208/s12249-019-1381-4 · doi:10.1208/s12249-019-1381-4
  102. Peulen, 2011, Diffusion of nanoparticles in a biofilm, Environ. Sci. Technol., 45, 3367, 10.1021/es103450g · DOI · Paper page
  103. Pibalpakdee, 2012, Diffusion and activity of antibiotics against Burkholderia pseudomallei biofilms, Int. J. Antimicrob. Agents, 39, 356, 10.1016/j.ijantimicag.2011.12.010 · DOI
  104. Pu, 2017, The antibacterial and antibiofilm efficacies of a liposomal peptide originating from rice bran protein against Listeria monocytogenes, Food Funct., 8, 4159, 10.1039/C7FO00994A · doi:10.1039/c7fo00994a
  105. Quan, 2022, Water in bacterial biofilms: pores and channels, storage and transport functions, Crit. Rev. Microbiol., 48, 283, 10.1080/1040841X.2021.1962802 · DOI
  106. Quinn, 2015, Cleaning and disinfecting environmental surfaces in health care: toward an integrated framework for infection and occupational illness prevention, Am. J. Infect. Control, 43, 424, 10.1016/j.ajic.2015.01.029 · DOI · Paper page
  107. Radovic-Moreno, 2012, Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics, ACS Nano, 6, 4279, 10.1021/nn3008383 · DOI · Paper page
  108. Ramasamy, 2016, Recent nanotechnology approaches for prevention and treatment of biofilm-associated infections on medical devices, Biomed. Res. Int., 2016, 1851242, 10.1155/2016/1851242 · DOI · Paper page
  109. Rao, 2022, Hypoxia-sensitive adjuvant loaded liposomes enhance the antimicrobial activity of azithromycin via phospholipase-triggered releasing for Pseudomonas aeruginosa biofilms eradication, Int. J. Pharm., 623, 10.1016/j.ijpharm.2022.121910 · DOI
  110. Rice, 2007, The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus, Proc. Natl. Acad. Sci. U.S.A., 104, 8113, 10.1073/pnas.0610226104 · DOI · Paper page
  111. Richter, 2017, Taking the silver bullet colloidal silver particles for the topical treatment of biofilm-related infections, ACS Appl Mater Interfaces, 9, 21631, 10.1021/acsami.7b03672 · DOI
  112. Roy, 2018, Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action, Virulence, 9, 522, 10.1080/21505594.2017.1313372 · DOI · Paper page
  113. Roy, 2021, Effects of environmental conditions (temperature, pH, and glucose) on biofilm formation of Salmonella enterica serotype Kentucky and virulence gene expression, Poult. Sci., 100, 10.1016/j.psj.2021.101209 · DOI
  114. Rukavina, 2016, Current trends in development of liposomes for targeting bacterial biofilms, Pharmaceutics, 8, 10.3390/pharmaceutics8020018 · DOI · Paper page
  115. Rukavina, 2016, Current trends in development of liposomes for targeting bacterial biofilms, Pharmaceutics, 8, 10.3390/pharmaceutics8020018 · DOI · Paper page
  116. Sahli, 2022, Recent advances in nanotechnology for eradicating bacterial biofilm, Theranostics, 12, 2383, 10.7150/thno.67296 · DOI · Paper page
  117. Scheeder, A., et al., 2023. Molecular mechanisms of liposome interactions with bacterial envelopes. bioRxiv, pp. 2023.10.07.561336. · doi:10.1101/2023.10.07.561336
  118. Scriboni, 2019, Fusogenic liposomes increase the antimicrobial activity of vancomycin against staphylococcus aureus biofilm, Front Pharmacol., 10, 1401, 10.3389/fphar.2019.01401 · DOI
  119. Selvakumar, 2014, A facile synthesis of silver nanoparticle with SERS and antimicrobial activity using Bacillus subtilis exopolysaccharides, J. Exp. Nanosci., 9, 1075, 10.1080/17458080.2013.778425 · doi:10.1080/17458080.2013.778425
  120. Solleti, 2015, Antimicrobial properties of liposomal azithromycin for Pseudomonas infections in cystic fibrosis patients, J. Antimicrob. Chemother., 70, 784, 10.1093/jac/dku452 · DOI
  121. Stewart, 2003, Diffusion in biofilms, J. Bacteriol., 185, 1485, 10.1128/JB.185.5.1485-1491.2003 · DOI · Paper page
  122. Talebi Bezmin Abadi, 2019, World health organization report: current crisis of antibiotic resistance, BioNanoScience, 9, 778, 10.1007/s12668-019-00658-4 · DOI · Paper page
  123. Tamilvanan, 2008, The potential of lipid- and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections, J. Control Release, 128, 2, 10.1016/j.jconrel.2008.01.006 · DOI
  124. Tarawneh, 2022, Assessment of persistent antimicrobial and anti-biofilm activity of p-HEMA hydrogel loaded with rifampicin and cefixime, Sci. Rep., 12, 3900, 10.1038/s41598-022-07953-3 · doi:10.1038/s41598-022-07953-3
  125. Tong, 2010, Influence of biofilm on the transport of fullerene (C60) nanoparticles in porous media, Water Res., 44, 1094, 10.1016/j.watres.2009.09.040 · DOI
  126. Tsai, 2023, Proteinase K/retinoic acid-loaded cationic liposomes as multifunctional anti-acne therapy to disorganize biofilm and regulate keratinocyte proliferation, Int. J. Nanomed., 18, 3879, 10.2147/IJN.S416966 · DOI
  127. Van Bambeke, 2008, The bacterial envelope as a target for novel anti-MRSA antibiotics, Trends Pharmacol. Sci., 29, 124, 10.1016/j.tips.2007.12.004 · DOI
  128. Vanic, 2019, Azithromycin-liposomes as a novel approach for localized therapy of cervicovaginal bacterial infections, Int. J. Nanomed., 14, 5957, 10.2147/IJN.S211691 · DOI
  129. Varposhti, 2014, Synergistic effects of bismuth thiols and various antibiotics against pseudomonas aeruginosa biofilm, Jundishapur J. Microbiol., 7, e9142, 10.5812/jjm.9142 · doi:10.5812/jjm.9142
  130. Verderosa, 2019, Bacterial biofilm eradication agents: a current review, Front Chem., 7, 824, 10.3389/fchem.2019.00824 · DOI · Paper page
  131. Vestby, 2020, Bacterial biofilm and its role in the pathogenesis of disease, Antibiotics (Basel), 9
  132. Wang, 2016, Fusion between fluid liposomes and intact bacteria: study of driving parameters and in vitro bactericidal efficacy, Int. J. Nanomed., 11, 4025, 10.2147/IJN.S55807 · DOI
  133. Wang, 2019, Lipid-based antimicrobial delivery-systems for the treatment of bacterial infections, Front Chem., 7, 872, 10.3389/fchem.2019.00872 · DOI · Paper page
  134. Wang, 2021, Liposome as a delivery system for the treatment of biofilm-mediated infections, J. Appl. Microbiol., 131, 2626, 10.1111/jam.15053 · DOI
  135. Wang, 2022, Proton-mediated burst of dual-drug loaded liposomes for biofilm dispersal and bacterial killing, J. Control Release, 352, 460, 10.1016/j.jconrel.2022.10.049 · DOI
  136. Wilking, 2013, Liquid transport facilitated by channels in Bacillus subtilis biofilms, Proc. Natl. Acad. Sci. U.S.A., 110, 848, 10.1073/pnas.1216376110 · DOI · Paper page
  137. Wright, 2022, Quorum sensing and quorum quenching with a focus on cariogenic and periodontopathic oral biofilms, Microorganisms, 10, 10.3390/microorganisms10091783 · DOI
  138. Xie, 2022, Cholesterol microdomain enhances the biofilm eradication of antibiotic liposomes, Adv. Healthc Mater., 11, e2101745, 10.1002/adhm.202101745 · DOI
  139. Xu, 2020, Near-infrared-controlled nanoplatform exploiting photothermal promotion of peroxidase-like and OXD-like activities for potent antibacterial and anti-biofilm therapies, ACS Appl. Mater. Interf., 12, 50260, 10.1021/acsami.0c14451 · DOI
  140. Xue, 2015, Lipid-based nanocarriers for RNA delivery, Curr. Pharm. Des., 21, 3140, 10.2174/1381612821666150531164540 · DOI · Paper page
  141. Yang, 2007, Effects of iron on DNA release and biofilm development by Pseudomonas aeruginosa, Microbiology (Reading), 153, 1318, 10.1099/mic.0.2006/004911-0 · DOI · Paper page
  142. Zahra, 2017, Evaluation and study of antimicrobial activity of nanoliposomal meropenem against Pseudomonas aeruginosa isolates, Artif. Cells Nanomed. Biotechnol., 45, 975, 10.1080/21691401.2016.1198362 · doi:10.1080/21691401.2016.1198362
  143. Zerillo, 2022, Antibiofilm and repair activity of ozonated oil in liposome, J. Microbial. Biotechnol., 15, 1422, 10.1111/1751-7915.13949 · DOI
  144. Zhang, 2020, Effects of isosorbide mononitrate loaded nanoparticles conjugated with anti-Staphylococcus aureus alpha-toxin on Staphylococcus aureus biofilms, Exp. Ther. Med., 19, 1267
  145. Zhang, 2022, Nanocarriers for combating biofilms: advantages and challenges, J. Appl. Microbiol., 133, 1273, 10.1111/jam.15640 · DOI
  146. Zhang, 2012, Surface science of DNA adsorption onto citrate-capped gold nanoparticles, Langmuir, 28, 3896, 10.1021/la205036p · DOI · Paper page
  147. Zhao, 2018, Near-infrared light-activated thermosensitive liposomes as efficient agents for photothermal and antibiotic synergistic therapy of bacterial biofilm, ACS Appl. Mater. Interf., 10, 14426, 10.1021/acsami.8b01327 · DOI · Paper page
  148. Zhu, 2010, Liposome combined porous beta-TCP scaffold: preparation, characterization, and anti-biofilm activity, Drug Deliv., 17, 391, 10.3109/10717541003762870 · DOI
  149. Zou, 2022, The relief of hypoxic microenvironment using an O2 self-sufficient fluorinated nanoplatform for enhanced photodynamic eradication of bacterial biofilms, Nano Res., 15, 1636, 10.1007/s12274-021-3712-5 · DOI

Cited by

See all 88

Metadata

Authors
Panthi, V. K., Fairfull-Smith, K. E., & Islam, N.
Venue
International Journal of Pharmaceutics
Publisher
Elsevier BV
Published
2024-04
Volume
655
Pages
124046
ISSN
0378-5173
Cited by
88
References
3
Language
en
Licence
Funders
Queensland University of Technology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Liposomal drug delivery strategies to eradicate bacterial biofilms: Challenges, recent advances, and future perspectives. https://app.cochat.ai/papers/10.1016/j.ijpharm.2024.124046
The paper
Panthi, V. K., Fairfull-Smith, K. E., & Islam, N. (2024). Liposomal drug delivery strategies to eradicate bacterial biofilms: Challenges, recent advances, and future perspectives. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2024.124046

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.